Skip to main content
Top
Published in: BMC Immunology 1/2004

Open Access 01-12-2004 | Research article

P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells

Authors: Lingwei Wang, Sten Eirik W Jacobsen, Anders Bengtsson, David Erlinge

Published in: BMC Immunology | Issue 1/2004

Login to get access

Abstract

Background

Extracellular nucleotides (ATP, ADP, UTP and UDP) exert a wide range of biological effects in blood cells mediated by multiple ionotropic P2X receptors and G protein-coupled P2Y receptors. Although pharmacological experiments have suggested the presence of several P2 receptor subtypes on monocytes and lymphocytes, some results are contradictory. Few physiological functions have been firmly established to a specific receptor subtype, partly because of a lack of truly selective agonists and antagonists. This stimulated us to investigate the expression of P2X and P2Y receptors in human lymphocytes and monocytes with a newly established quantitative mRNA assay for P2 receptors. In addition, we describe for the first time the expression of P2 receptors in CD34+ stem and progenitor cells implicating a potential role of P2 receptors in hematopoietic lineage and progenitor/stem cell function.

Results

Using a quantitative mRNA assay, we assessed the hypothesis that there are specific P2 receptor profiles in inflammatory cells. The P2X4 receptor had the highest expression in lymphocytes and monocytes. Among the P2Y receptors, P2Y12 and P2Y2 had highest expression in lymphocytes, while the P2Y2 and P2Y13 had highest expression in monocytes. Several P2 receptors were expressed (P2Y2, P2Y1, P2Y12, P2Y13, P2Y11, P2X1, P2X4) in CD34+ stem and progenitor cells.

Conclusions

The most interesting findings were the high mRNA expression of P2Y12 receptors in lymphocytes potentially explaining the anti-inflammatory effects of clopidogrel, P2Y13 receptors in monocytes and a previously unrecognised expression of P2X4 in lymphocytes and monocytes. In addition, for the first time P2 receptor mRNA expression patterns was studied in CD34+ stem and progenitor cells. Several P2 receptors were expressed (P2Y2, P2Y1, P2Y12, P2Y13, P2Y11, P2X1, P2X4), indicating a role in differentiation and proliferation. Thus, it is possible that specific antibodies to P2 receptors could be used to identify progenitors for monocytes, lymphocytes and megakaryocytes.
Appendix
Available only for authorised users
Literature
2.
go back to reference Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A, Torboli M, Bolognesi G, Baricordi OR: Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood. 2001, 97: 587-600. 10.1182/blood.V97.3.587.CrossRefPubMed Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A, Torboli M, Bolognesi G, Baricordi OR: Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood. 2001, 97: 587-600. 10.1182/blood.V97.3.587.CrossRefPubMed
3.
go back to reference Sak K, Boeynaems JM, Everaus H: Involvement of P2Y receptors in the differentiation of haematopoietic cells. J Leukoc Biol. 2003, 73: 442-447. 10.1189/jlb.1102561.CrossRefPubMed Sak K, Boeynaems JM, Everaus H: Involvement of P2Y receptors in the differentiation of haematopoietic cells. J Leukoc Biol. 2003, 73: 442-447. 10.1189/jlb.1102561.CrossRefPubMed
4.
go back to reference von Kugelgen I, Wetter A: Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch Pharmacol. 2000, 362: 310-323. 10.1007/s002100000310.CrossRefPubMed von Kugelgen I, Wetter A: Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch Pharmacol. 2000, 362: 310-323. 10.1007/s002100000310.CrossRefPubMed
5.
go back to reference Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, Conley PB: Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature. 2001, 409: 202-207. 10.1038/35051599.CrossRefPubMed Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, Conley PB: Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature. 2001, 409: 202-207. 10.1038/35051599.CrossRefPubMed
6.
go back to reference Norenberg W, Illes P: Neuronal P2X receptors: localisation and functional properties. Naunyn Schmiedebergs Arch Pharmacol. 2000, 362: 324-339. 10.1007/s002100000311.CrossRefPubMed Norenberg W, Illes P: Neuronal P2X receptors: localisation and functional properties. Naunyn Schmiedebergs Arch Pharmacol. 2000, 362: 324-339. 10.1007/s002100000311.CrossRefPubMed
7.
go back to reference Khakh BS, Burnstock G, Kennedy C, King BF, North RA, Seguela P, Voigt M, Humphrey PP: International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev. 2001, 53: 107-118.PubMed Khakh BS, Burnstock G, Kennedy C, King BF, North RA, Seguela P, Voigt M, Humphrey PP: International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev. 2001, 53: 107-118.PubMed
8.
go back to reference Wang L, Östberg O, Wihlborg AK, Brogren H, Jern S, Erlinge D: Quantification of ADP and ATP Receptor Expression in Human Platelets. J Thromb Haemost. 2003, 1: 330-336. 10.1046/j.1538-7836.2003.00070.x.CrossRefPubMed Wang L, Östberg O, Wihlborg AK, Brogren H, Jern S, Erlinge D: Quantification of ADP and ATP Receptor Expression in Human Platelets. J Thromb Haemost. 2003, 1: 330-336. 10.1046/j.1538-7836.2003.00070.x.CrossRefPubMed
9.
go back to reference Jneid H, Bhatt DL, Corti R, Badimon JJ, Fuster V, Francis GS: Aspirin and Clopidogrel in Acute Coronary Syndromes: Therapeutic Insights From the CURE Study. Arch Intern Med. 2003, 163: 1145-1153. 10.1001/archinte.163.10.1145.CrossRefPubMed Jneid H, Bhatt DL, Corti R, Badimon JJ, Fuster V, Francis GS: Aspirin and Clopidogrel in Acute Coronary Syndromes: Therapeutic Insights From the CURE Study. Arch Intern Med. 2003, 163: 1145-1153. 10.1001/archinte.163.10.1145.CrossRefPubMed
10.
go back to reference CAPRIE: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996, 348: 1329-1339. 10.1016/S0140-6736(96)09457-3.CrossRef CAPRIE: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996, 348: 1329-1339. 10.1016/S0140-6736(96)09457-3.CrossRef
11.
12.
go back to reference Andreesen R, Bross KJ, Osterholz J, Emmrich F: Human macrophage maturation and heterogeneity: analysis with a newly generated set of monoclonal antibodies to differentiation antigens. Blood. 1986, 67: 1257-1264.PubMed Andreesen R, Bross KJ, Osterholz J, Emmrich F: Human macrophage maturation and heterogeneity: analysis with a newly generated set of monoclonal antibodies to differentiation antigens. Blood. 1986, 67: 1257-1264.PubMed
13.
go back to reference Humphreys BD, Dubyak GR: Modulation of P2X7 nucleotide receptor expression by pro- and anti-inflammatory stimuli in THP-1 monocytes. J Leukoc Biol. 1998, 64: 265-273.PubMed Humphreys BD, Dubyak GR: Modulation of P2X7 nucleotide receptor expression by pro- and anti-inflammatory stimuli in THP-1 monocytes. J Leukoc Biol. 1998, 64: 265-273.PubMed
14.
go back to reference Ferrari D, Stroh C, Schulze-Osthoff K: P2X7/P2Z purinoreceptor-mediated activation of transcription factor NFAT in microglial cells. J Biol Chem. 1999, 274: 13205-13210. 10.1074/jbc.274.19.13205.CrossRefPubMed Ferrari D, Stroh C, Schulze-Osthoff K: P2X7/P2Z purinoreceptor-mediated activation of transcription factor NFAT in microglial cells. J Biol Chem. 1999, 274: 13205-13210. 10.1074/jbc.274.19.13205.CrossRefPubMed
15.
go back to reference Wang L, Karlsson L, Moses S, Hultgårdh-Nilsson A, Andersson M, Borna C, Gudbjartsson T, Jern S, Erlinge D: P2 Receptor Profiles in Human Vascular Smooth Muscle and Endothelial Cells. J Cardiovasc Pharmacol. 2002, 40: 841-853. 10.1097/00005344-200212000-00005.CrossRefPubMed Wang L, Karlsson L, Moses S, Hultgårdh-Nilsson A, Andersson M, Borna C, Gudbjartsson T, Jern S, Erlinge D: P2 Receptor Profiles in Human Vascular Smooth Muscle and Endothelial Cells. J Cardiovasc Pharmacol. 2002, 40: 841-853. 10.1097/00005344-200212000-00005.CrossRefPubMed
16.
go back to reference Di Virgilio F, Borea PA, Illes P: P2 receptors meet the immune system. Trends Pharmacol Sci. 2001, 22: 5-7. 10.1016/S0165-6147(00)01574-1.CrossRefPubMed Di Virgilio F, Borea PA, Illes P: P2 receptors meet the immune system. Trends Pharmacol Sci. 2001, 22: 5-7. 10.1016/S0165-6147(00)01574-1.CrossRefPubMed
17.
go back to reference Conigrave AD, Fernando KC, Gu B, Tasevski V, Zhang W, Luttrell BM, Wiley JS: P2Y(11) receptor expression by human lymphocytes: evidence for two cAMP-linked purinoceptors. Eur J Pharmacol. 2001, 426: 157-163. 10.1016/S0014-2999(01)01222-5.CrossRefPubMed Conigrave AD, Fernando KC, Gu B, Tasevski V, Zhang W, Luttrell BM, Wiley JS: P2Y(11) receptor expression by human lymphocytes: evidence for two cAMP-linked purinoceptors. Eur J Pharmacol. 2001, 426: 157-163. 10.1016/S0014-2999(01)01222-5.CrossRefPubMed
18.
go back to reference Vivekananthan DP, Bhatt DL, Chew DP, Chan AW, Moliterna DJ, Ellis SG, Topol E: Clopidogrel pretreatment prior to percutaneous coronary intervention attenuates periprocedural rise of C-reactive protein. J Am Coll Cardiol. 2003, 41: 1075-1165. Vivekananthan DP, Bhatt DL, Chew DP, Chan AW, Moliterna DJ, Ellis SG, Topol E: Clopidogrel pretreatment prior to percutaneous coronary intervention attenuates periprocedural rise of C-reactive protein. J Am Coll Cardiol. 2003, 41: 1075-1165.
19.
go back to reference Gargett CE, Wiley JS: The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes. Br J Pharmacol. 1997, 120: 1483-1490.PubMedCentralCrossRefPubMed Gargett CE, Wiley JS: The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes. Br J Pharmacol. 1997, 120: 1483-1490.PubMedCentralCrossRefPubMed
20.
go back to reference Sluyter R, Barden JA, Wiley JS: Detection of P2X purinergic receptors on human B lymphocytes. Cell Tissue Res. 2001, 304: 231-236. 10.1007/s004410100372.CrossRefPubMed Sluyter R, Barden JA, Wiley JS: Detection of P2X purinergic receptors on human B lymphocytes. Cell Tissue Res. 2001, 304: 231-236. 10.1007/s004410100372.CrossRefPubMed
21.
22.
go back to reference Wilkin F, Duhant X, Bruyns C, Suarez-Huerta N, Boeynaems JM, Robaye B: The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells. J Immunol. 2001, 166: 7172-7177.CrossRefPubMed Wilkin F, Duhant X, Bruyns C, Suarez-Huerta N, Boeynaems JM, Robaye B: The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells. J Immunol. 2001, 166: 7172-7177.CrossRefPubMed
23.
go back to reference Zhang FL, Luo L, Gustafson E, Palmer K, Qiao X, Fan X, Yang S, Laz TM, Bayne M, Monsma F., Jr.: P2Y(13): identification and characterization of a novel Galphai-coupled ADP receptor from human and mouse. J Pharmacol Exp Ther. 2002, 301: 705-713. 10.1124/jpet.301.2.705.CrossRefPubMed Zhang FL, Luo L, Gustafson E, Palmer K, Qiao X, Fan X, Yang S, Laz TM, Bayne M, Monsma F., Jr.: P2Y(13): identification and characterization of a novel Galphai-coupled ADP receptor from human and mouse. J Pharmacol Exp Ther. 2002, 301: 705-713. 10.1124/jpet.301.2.705.CrossRefPubMed
24.
go back to reference Eschke D, Wust M, Hauschildt S, Nieber K: Pharmacological characterization of the P2X(7) receptor on human macrophages using the patch-clamp technique. Naunyn Schmiedebergs Arch Pharmacol. 2002, 365: 168-171. 10.1007/s00210-001-0501-2.CrossRefPubMed Eschke D, Wust M, Hauschildt S, Nieber K: Pharmacological characterization of the P2X(7) receptor on human macrophages using the patch-clamp technique. Naunyn Schmiedebergs Arch Pharmacol. 2002, 365: 168-171. 10.1007/s00210-001-0501-2.CrossRefPubMed
26.
go back to reference Verfaillie CM: Hematopoietic stem cells for transplantation. Nat Immunol. 2002, 3: 314-317. 10.1038/ni0402-314.CrossRefPubMed Verfaillie CM: Hematopoietic stem cells for transplantation. Nat Immunol. 2002, 3: 314-317. 10.1038/ni0402-314.CrossRefPubMed
27.
go back to reference Sitnicka E, Buza-Vidas N, Larsson S, Nygren JM, Liuba K, Jacobsen SE: Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells. Blood. 2003, 102: 881-886. 10.1182/blood-2002-06-1694.CrossRefPubMed Sitnicka E, Buza-Vidas N, Larsson S, Nygren JM, Liuba K, Jacobsen SE: Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells. Blood. 2003, 102: 881-886. 10.1182/blood-2002-06-1694.CrossRefPubMed
28.
go back to reference Wang L, Andersson M, Karlsson L, Watson MA, Cousens DJ, Jern S, Erlinge D: Increased mitogenic and decreased contractile P2 receptors in smooth muscle cells by shear stress in human vessels with intact endothelium. Arterioscler Thromb Vasc Biol. 2003, 23: 1370-1376. 10.1161/01.ATV.0000080350.37408.5A.CrossRefPubMed Wang L, Andersson M, Karlsson L, Watson MA, Cousens DJ, Jern S, Erlinge D: Increased mitogenic and decreased contractile P2 receptors in smooth muscle cells by shear stress in human vessels with intact endothelium. Arterioscler Thromb Vasc Biol. 2003, 23: 1370-1376. 10.1161/01.ATV.0000080350.37408.5A.CrossRefPubMed
29.
go back to reference Borna C, Wang L, Gudbjartsson T, Karlsson L, Jern S, Malmsjo M, Erlinge D: Contractions in human coronary bypass vessels stimulated by extracellular nucleotides. Ann Thorac Surg. 2003, 76: 50-57. 10.1016/S0003-4975(03)00008-0.CrossRefPubMed Borna C, Wang L, Gudbjartsson T, Karlsson L, Jern S, Malmsjo M, Erlinge D: Contractions in human coronary bypass vessels stimulated by extracellular nucleotides. Ann Thorac Surg. 2003, 76: 50-57. 10.1016/S0003-4975(03)00008-0.CrossRefPubMed
Metadata
Title
P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells
Authors
Lingwei Wang
Sten Eirik W Jacobsen
Anders Bengtsson
David Erlinge
Publication date
01-12-2004
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2004
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/1471-2172-5-16

Other articles of this Issue 1/2004

BMC Immunology 1/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine